Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Golam M. Khandaker"'
Autor:
Ana Luiza Arruda, Golam M. Khandaker, Andrew P. Morris, George Davey Smith, Laura M. Huckins, Eleftheria Zeggini
Publikováno v:
Schizophrenia, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract Multimorbidity represents an increasingly important public health challenge with far-reaching implications for health management and policy. Mental health and metabolic diseases have a well-established epidemiological association. In this st
Externí odkaz:
https://doaj.org/article/3b75b79866b845a5a6b0e06d19062b74
Autor:
Wing Tse, Golam M. Khandaker, Huiquan Zhou, Hao Luo, Wai Ching Yan, Man Wah Siu, Lap Tak Poon, Edwin Ho Ming Lee, Qingpeng Zhang, Rachel Upthegrove, Emanuele F. Osimo, Benjamin I. Perry, Sherry Kit Wa Chan
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 47, Iss , Pp 101089- (2024)
Summary: Background: Metabolic syndrome (MetS) is common following first-episode psychosis (FEP), contributing to substantial morbidity and mortality. The Psychosis Metabolic Risk Calculator (PsyMetRiC), a risk prediction algorithm for MetS following
Externí odkaz:
https://doaj.org/article/1eceb9313fdf453ab4018f6244637f98
Autor:
Noushin Saadullah Khani, Marius Cotic, Baihan Wang, Rosemary Abidoph, Georgina Mills, Alvin Richards-Belle, Benjamin I. Perry, Golam M. Khandaker, Elvira Bramon
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Background: Individuals with a diagnosis of schizophrenia are known to be at high risk of premature mortality due to poor physical health, especially cardiovascular disease, diabetes, and obesity. The reasons for these physical health outcomes within
Externí odkaz:
https://doaj.org/article/03bbdc30703c4252b88a1658a38614e3
Autor:
Amelia J. Edmondson-Stait, Xueyi Shen, Mark J. Adams, Miruna C. Barbu, Hannah J. Jones, Veronique E. Miron, Judith Allardyce, James P. Boardman, Stephen M. Lawrie, Andrew M. McIntosh, Golam M. Khandaker, Alex S.F. Kwong, Heather C. Whalley
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 26, Iss , Pp 100528- (2022)
Inflammation is implicated in depression and psychosis, including association of childhood inflammatory markers on the subsequent risk of developing symptoms. However, it is unknown whether early-life inflammatory markers are associated with the numb
Externí odkaz:
https://doaj.org/article/f88a130972c04c3db498c86226a54915
Autor:
Benjamin I. Perry, Frederik Vandenberghe, Nathalia Garrido-Torres, Emanuele F. Osimo, Marianna Piras, Javier Vazquez-Bourgon, Rachel Upthegrove, Claire Grosu, Victor Ortiz-Garcia De La Foz, Peter B. Jones, Nermine Laaboub, Miguel Ruiz-Veguilla, Jan Stochl, Celine Dubath, Manuel Canal-Rivero, Pavan Mallikarjun, Aurélie Reymond-Delacrétaz, Nicolas Ansermot, Emilio Fernandez-Egea, Severine Crettol, Franziska Gamma, Kerstin J. Plessen, Philippe Conus, Golam M. Khandaker, Graham K. Murray, Chin B. Eap, Benedicto Crespo-Facorro
Publikováno v:
The Lancet Regional Health. Europe, Vol 22, Iss , Pp 100493- (2022)
Summary: Background: Cardiometabolic dysfunction is common in young people with psychosis. Recently, the Psychosis Metabolic Risk Calculator (PsyMetRiC) was developed and externally validated in the UK, predicting up-to six-year risk of metabolic syn
Externí odkaz:
https://doaj.org/article/6f4f9f85cd3b4ce5b59625bb3d5e11b3
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The association between sexual and physical abuse and subsequent depression is well-established, but the associations with specific depressive symptoms and sex differences remain relatively understudied. We investigated the associ
Externí odkaz:
https://doaj.org/article/3b926fa4c2f4468eac9c9bf43ff18440
Autor:
Emanuele F. Osimo, Luke Baxter, Jan Stochl, Benjamin I. Perry, Stephen A. Metcalf, Setor K. Kunutsor, Jari A. Laukkanen, Marie Kim Wium-Andersen, Peter B. Jones, Golam M. Khandaker
Publikováno v:
npj Schizophrenia, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Meta-analyses of cross-sectional studies suggest that patients with psychosis have higher circulating levels of C-reactive protein (CRP) compared with healthy controls; however, cause and effect is unclear. We examined the prospective associ
Externí odkaz:
https://doaj.org/article/34fac0cb5f19474f996fc76e386941c2
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 19, Iss , Pp 100409- (2022)
Background: The link between inflammation and depression has been investigated extensively. Cognitive dysfunction in depression is an unmet treatment need. A better understanding of possible links between inflammation and cognition in people with dep
Externí odkaz:
https://doaj.org/article/9fb54807a56d49fbad75020fa14a59de
Publikováno v:
Comprehensive Psychoneuroendocrinology, Vol 8, Iss , Pp 100079- (2021)
Whether depressed patients with evidence of inflammation are more appropriate candidates for immunotherapies is being tested in several clinical trials, which are selecting patients based on elevated C-reactive protein (CRP) and inflammation-related
Externí odkaz:
https://doaj.org/article/9b97079913e84771894053a8eb6e0a72
Autor:
Zheng Ye, Nils Kappelmann, Sylvain Moser, George Davey Smith, Stephen Burgess, Peter B. Jones, Golam M. Khandaker
Publikováno v:
EClinicalMedicine, Vol 38, Iss , Pp 100992- (2021)
Background: Concentrations of C-reactive protein (CRP), interleukin 6 (IL-6) and other inflammatory markers are elevated in people with depression and anxiety compared to controls, but evidence for disorder-specificity, linearity and potential causal
Externí odkaz:
https://doaj.org/article/3d48e4ee0522460796e232c85a04c5d7